Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03837678 · ClinicalTrials.gov registry record
Epithelioid Sarcoma Natural History Study
A clinical trial, sponsored by Epizyme.
- Completed
- Registry status
- 74
- Enrollment target
NCT03837678 is a clinical trial that has completed, run by Epizyme. The registered enrollment target is 74 participants.
The verdict
NCT03837678 has completed, sponsored by Epizyme.
- COMPLETED
- Registry status
- 74 participants
- Enrollment target
Study Summary
This study is a multi-center, non-interventional retrospective medical records review. The study will involve identification of medical records of patients with confirmed locally advanced unresectable or metastatic ES, who initiated systemic therapy between January 1, 2000 and December 31, 2017. Data for the chart review will be extracted retrospectively from eligible subjects' charts (electronic or paper). Information on prior surgical treatment and neoadjuvant/adjuvant therapies for ES will also be collected for ineligible subjects with a locally advanced or metastatic ES diagnosis who did not initiated systemic therapy. Data collected will be anonymized by the investigators and will not be traceable back to individual subjects by the sponsor (i.e., no protected health information \[PHI\] will be collected).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2018-06-04 |
| Est. Completion | 2021-09-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03837678
The ClinicalTrials.gov registry entry for NCT03837678 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 74 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Epizyme, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03837678 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03837678 about?
NCT03837678 is a clinical study titled "Epithelioid Sarcoma Natural History Study". This study is a multi-center, non-interventional retrospective medical records review. The study will involve identification of medical records of patients with confirmed locally advanced unresectable or metastatic ES, who initiated systemic therapy between January 1, 2000 and December 31, 2017. Da...
What is the current status of trial NCT03837678?
This trial is currently completed. The enrollment target is 74 participants. The study started on 2018-06-04. Estimated completion is 2021-09-02.
Who is sponsoring clinical trial NCT03837678?
This trial is sponsored by Epizyme, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.